267 related articles for article (PubMed ID: 19332244)
1. Management of women with newly diagnosed ovarian cancer.
Krasner C; Duska L
Semin Oncol; 2009 Apr; 36(2):91-105. PubMed ID: 19332244
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
3. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
Sugiyama T; Yoshizaki A; Hatayama S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
[TBL] [Abstract][Full Text] [Related]
4. Role of chemotherapy in the management of epithelial ovarian cancer.
Reed NS; Sadozye AH
Expert Rev Anticancer Ther; 2005 Feb; 5(1):139-47. PubMed ID: 15757446
[TBL] [Abstract][Full Text] [Related]
5. Update on the management of ovarian cancer.
Ozols RF
Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
[TBL] [Abstract][Full Text] [Related]
6. [Ovarian cancer].
Onda T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1735-9. PubMed ID: 18030006
[TBL] [Abstract][Full Text] [Related]
7. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
8. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
Muggia FM
Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
[TBL] [Abstract][Full Text] [Related]
9. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
Huober J; Meyer A; Wagner U; Wallwiener D
J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
[TBL] [Abstract][Full Text] [Related]
10. [Ovarian cancer from the standpoint of medical oncology].
Kato Y; Katsumata N
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
[TBL] [Abstract][Full Text] [Related]
11. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS
Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221
[TBL] [Abstract][Full Text] [Related]
14. Current aspects of adjuvant therapy of early stage ovarian cancer.
McGuire WP
Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
[TBL] [Abstract][Full Text] [Related]
15. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
Eisenkop SM
Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983
[No Abstract] [Full Text] [Related]
16. [Neoadjuvant chemotherapy for advanced ovarian cancer].
Perlman S; Ben-Arie A
Harefuah; 2010 Jun; 149(6):377-81, 402. PubMed ID: 20941929
[TBL] [Abstract][Full Text] [Related]
17. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer].
Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P
Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
19. [Trends in comprehensive treatment for gynecologic malignancies].
Yakushiji M; Fujiyoshi K; Komai K; Imamura K
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():145-56. PubMed ID: 10410669
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
Tummala MK; Alagarsamy S; McGuire WP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]